SITU Operational Lead
I have been working in NDS since May 2018. Prior to this I have had an interesting career in clinical trials, with NDORMS and CTSU; commissioning and delivery of NHS services; public health, and quality assurance. This position gives me opportunity to take what I have learnt in these arenas to the delivery of clinical trials within SITU as Operational Lead.
Outside work, interests include being chair of the governing body at my son's (Matias) special needs school and treasurer for the Cri du chat syndrome support group - a national charity that supports families with Matias's condition.
Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.
Sharp Collaborative Group None., (2010), American heart journal, 160, 785 - 794.e10